CNBC Pro

Buy Teva Pharmaceutical amid confluence of positive news, Bernstein says

A banner displays a Teva Pharmaceutical Industries Ltd. logo at the entrance to the company's new factory in Godollo, Hungary.
Akos Stiller | Bloomberg | Getty Images

A recent bout of good news makes Teva Pharmaceutical a good buy for investors, even though the company faces ongoing opioid litigation, according to Bernstein.

More In Street Calls

CNBC ProHere are Friday's biggest analyst calls of the day: Apple, FedEx, Coinbase, Honeywell, Micron & more
CNBC ProEnergy stocks are the best bet in the market right now, says JPMorgan
CNBC ProBank of America downgrades Micron, says recovery is 'unlikely' this year